Trends in the Use of Neoadjuvant Chemotherapy for Advanced Ovarian Cancer in the United States

    loading  Checking for direct PDF access through Ovid

Abstract

(Abstracted from Gynecol Oncol 2016;143:236–240)

The historic standard of care for women with advanced ovarian cancer has been primary cytoreductive surgery followed by adjuvant chemotherapy. In the past decade, however, treatment with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery has emerged as an alternative treatment modality for patients with advanced disease.

Related Topics

    loading  Loading Related Articles